Skip to main content
. 2022 Apr 8;13:800015. doi: 10.3389/fneur.2022.800015

Table 1.

Demographics, clinical characteristics, and outcome data of the included patients with traumatic brain injury (TBI) stratified by the Glasgow Coma Scale (GCS), N = 592.

Variables Initial GCS 14-15 (mild) N = 566 Initial GCS 9-13 (moderate) N = 20 Initial GCS 3-8 (severe) N = 6
Demographics
Age, years, median [IQR] 62 [45;74] 69 [38;76] 41 [35;54]
   – > 65 years, n/N (%) 257/566 (45.4) 12/20 (60.0) 1/6 (16.7)
Male, n/N (%) 329/566 (58.1) 13/20 (65.0) 5/6 (83.3)
Clinical characteristics
Charlson comorbidity index
0, n/N (%) 161/566 (28.4) 6/19 (31.6) 3/6 (50)
1–2, n/N (%) 138/566 (24.4) 6/19 (31.6) 2/6 (33.3)
3–4, n/N (%) 159/566 (28.1) 5/19 (26.3) 1/6 (7, 16)
≥5, n/N (%) 108/566 (19.1) 2/19 (10.5) 0/6 (0.0)
Antiplatelet/-coagulant treatment
Yes, n/N (%) 144/556 (25.9) 4/19 (21.0) 0/6 (0.0)
   – Acetylsalicylic acid, n/N (%) 65/144 (45.1) 2/4 (50.0) -
   – ADP-receptor antagonist, n/N (%) 32/144 (22.2) 0/4 (0.0) -
   – Vitamin K antagonist, n/N (%) 18/144 (12.5) 2/4 (50.0) -
   – NOAC, n/N (%) 32/144 (22.2) 0/4 (0.0) -
Trauma mechanism
Traffic, n/N (%) 143/557 (25.6) 4/19 (21.0) 3/6 (50.0)
Fall <2m, n/N (%) 350/557 (62.8) 9/19 (47.4) 2/6 (33.3)
Fall >2m, n/N (%) 17/557 (3.1) 3/19 (15.8) 1/6 (16.7)
Violence, n/N (%) 14/557 (2.5) 0/19 (0.0) 0/6 (0.0)
Other, n/N (%) 33/557(5.9) 3/19 (15.8) 0/6 (0.0)
Additional symptoms
Loss of consciousness and/or amnesia, n/N (%) 142/566 (25.1) - -
Vomiting, n/N (%) 23/566 (4.1) - -
Suspected intake of alcohol/drugs prior to trauma
Yes, n/N (%) 161/521 (30.9) 6/18(33.3) 3/4 (75.0)
Bone fracture
Yes, n/N (%) 21/566 () 0/20 (0) 0/6 (0)
CT examination
Yes, n/N (%) 344/566 (60.7) 17/20 (85.0) 5/6 (83.3)
Clinical outcome
Intracranial lesion 32/566 (5.7) 8/20 (40.0) 4/6 (66.7)
   – Neurosurgical observation
and/or intervention
4/32 (12.5) 5/8 (62.5) 4/4 (100.0)
   – Death within 7 days due to TBI 2/566 (0.4) 1/20 (5.0) 0/6 (0.0)

TBI, Traumatic Brain Injury; GCS, Glasgow Coma Scale; IQR, Interquartile range.